Reed Douglas MD
Insider CIK 1291262 · PHAS 10% owner · TLOG Director · CLSD 10% owner · GTHX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 52,690 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 994 | $5.00 | $5.0K | 40,420 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 41,414 | $0.12 | $5.0K | 41,414 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 104 | $5.00 | $520 | 13,558 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 4,309 | $0.12 | $517 | 13,662 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 4,309 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 1,139 | $5.00 | $5.7K | 149,320 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 47,458 | $0.12 | $5.7K | 150,459 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 47,458 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 42 | $5.00 | $210 | 94,874 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 1,731 | $0.12 | $208 | 94,916 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 1,731 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 458 | $5.00 | $2.3K | 1,044,764 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 19,061 | $0.12 | $2.3K | 1,045,222 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 19,061 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 42,530 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 3,862 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 4,846 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 174,699 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 13,609 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 1,044,764 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 94,874 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 149,320 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 13,558 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 40,420 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 272,107 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 24,709 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 226,061 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | X Exercise deriv | 2018-10-22 | 2018-10-24 | 41,414 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 4,846 | — | $0 | 4,846 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 12,487 | $5.00 | $62.4K | 163,099 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 150,612 | — | $0 | 150,612 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 137,513 | $5.00 | $687.6K | 1,820,933 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 266,481 | — | $0 | 266,481 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 52,690 | — | $0 | 52,690 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 150,000 | $5.00 | $750.0K | 416,481 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 1,683,420 | — | $0 | 1,683,420 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-30 | 2018-06-01 | 41,710 | $48.00 | $2.00M | 3,237,711 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-30 | 2018-06-01 | 758,290 | $48.00 | $36.40M | 3,279,421 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-23 | 2018-05-23 | 474 | $50.50 | $23.9K | 4,037,737 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-23 | 2018-05-23 | 26 | $50.50 | $1.3K | 4,037,711 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-22 | 2018-05-23 | 5,592 | $50.86 | $284.4K | 4,038,519 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-22 | 2018-05-23 | 308 | $50.69 | $15.6K | 4,038,211 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-21 | 2018-05-23 | 474 | $52.13 | $24.7K | 4,044,137 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-21 | 2018-05-23 | 26 | $52.13 | $1.4K | 4,044,111 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-21 | 2018-05-23 | 1,595 | $51.06 | $81.4K | 4,044,611 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-21 | 2018-05-23 | 29,005 | $51.16 | $1.48M | 4,046,206 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | J Other | 2017-11-30 | 2017-12-04 | 99,513 | — | $0 | 4,074,216 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | J Other | 2017-11-30 | 2017-12-04 | 995 | — | $0 | 4,075,211 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 6,568,527 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 1,009,693 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 2,584,959 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 1,318,681 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion | 2017-05-22 | 2017-05-24 | 212,419 | — | $0 | 212,419 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion | 2017-05-22 | 2017-05-24 | 3,728,464 | — | $0 | 3,728,464 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | P Buy | 2017-05-22 | 2017-05-24 | 133,333 | $15.00 | $2.00M | 3,861,797 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion | 2017-05-22 | 2017-05-24 | 99,513 | — | $0 | 99,513 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-19 | 2017-01-19 | 6,478 | $8.22 | $53.2K | 1,757,719 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-19 | 2017-01-19 | 7,592 | $8.22 | $62.4K | 2,060,514 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-18 | 2017-01-19 | 10,457 | $8.64 | $90.3K | 1,764,197 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-18 | 2017-01-19 | 12,258 | $8.64 | $105.9K | 2,068,106 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-17 | 2017-01-19 | 8,366 | $8.92 | $74.6K | 1,774,654 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-17 | 2017-01-19 | 9,806 | $8.92 | $87.5K | 2,080,364 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 337,897 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 2,035,908 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 21,705 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 432,941 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 689,388 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 1,805 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 19,900 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 337,898 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 432,940 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 689,388 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 2,035,907 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion | 2016-06-07 | 2016-06-07 | 1,598,223 | — | $0 | 1,654,248 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2016-06-07 | 2016-06-07 | 414,286 | $7.00 | $2.90M | 2,090,170 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise | 2016-06-07 | 2016-06-07 | 21,705 | $0.02 | $434 | 1,675,953 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2016-06-07 | 2016-06-07 | 69 | $7.00 | $483 | 1,675,884 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2016-06-07 | 2016-06-07 | 107,142 | $7.00 | $750.0K | 1,783,020 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2016-06-07 | 2016-06-07 | 69 | $7.00 | $483 | 1,675,878 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise | 2016-06-07 | 2016-06-07 | 21,705 | $0.02 | $434 | 1,675,947 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion | 2016-06-07 | 2016-06-07 | 1,598,219 | — | $0 | 1,654,242 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | A Award deriv | 2015-01-28 | 2015-01-30 | 10,000 | $5.25 | $52.5K | 30,000 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 780,980 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion deriv | 2013-12-17 | 2013-12-19 | 278,315 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | X Exercise deriv | 2013-12-17 | 2013-12-19 | 7,590 | — | $0 | 0 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 780,980 | — | $0 | 923,837 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | X Exercise | 2013-12-17 | 2013-12-19 | 7,590 | $6.40 | $48.6K | 1,209,742 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | P Buy | 2013-12-17 | 2013-12-19 | 142,857 | $7.00 | $1000.0K | 142,857 | SEC↗ |
| TLOG TETRALOGIC PHARMACEUTICALS | C Conversion | 2013-12-17 | 2013-12-19 | 278,315 | $7.00 | $1.95M | 1,202,152 | SEC↗ |